Abstract:One of the barriers for breast cancer prevention and treatment is our poor understanding of the dynamic cellular shifts that naturally occur within the breast and how these changes contribute to tumour initiation. In this study we report the use of single cell RNA sequencing (scRNAseq) to compile a Human Breast Cell Atlas (HBCA) assembled from 55 donors that had undergone reduction mammoplasties or risk reduction mammoplasties. The data from more than 800,000 cells identified 41 cell subclusters distributed ac… Show more
“…Epithelial cell types were annotated using CD49f/EpCAM markers as done previously into mature luminal (ML), luminal progenitors (LP) and basal cells 11 . These cell clusters have been described with various names in the literature 7,8,12 . In a recent breast cell annotation event organized by Chan-Zuckerberg Initiative that included several research groups involved in developing single cell atlas of the breast, the following terminologies were suggested: luminal hormone sensing (LHS), luminal adaptive secretory precursor cells (LASP) and basal-myoepithelial (BM) cells for mature luminal, luminal progenitor, and basal cells, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…Murrow et al characterized premenopausal breast tissue at the single cell level to determine coordinated transcriptional programs that alter in response to changing hormonal levels 9 . Two other single cell studies using reduction mammoplasty samples identified three major epithelial cell types in the breast 10,12 . However, there remains a lack of information in differences in cell state based on genetic ancestry and relationship between cell state as defined by transcriptome and chromatin accessibility status.…”
Single nuclei analysis is allowing robust classification of cell types in an organ that helps to establish relationships between cell-type specific gene expression and chromatin accessibility status of gene regulatory regions. Using breast tissues of 92 healthy donors of various genetic ancestry, we have developed a comprehensive chromatin accessibility and gene expression atlas of human breast tissues. Integrated analysis revealed 10 distinct cell types in the healthy breast, which included three major epithelial cell subtypes (luminal hormone sensing, luminal adaptive secretory precursor, and basal-myoepithelial cells), two endothelial subtypes, two adipocyte subtypes, fibroblasts, T-cells, and macrophages. By integrating gene expression signatures derived from epithelial cell subtypes with spatial transcriptomics, we identify specific gene expression differences between lobular and ductal epithelial cells and age-associated changes in epithelial cell gene expression patterns and signaling networks. Among various cell types, luminal adaptive secretory cells and fibroblasts showed genetic ancestry dependent variability. A subpopulation of luminal adaptive secretory cells with alveolar progenitor (AP) cell state were enriched in Indigenous American (IA) ancestry and fibroblast populations were distinct in African ancestry. ESR1 expression pattern was distinctly different in cells from IA compared to the rest, with a high level of ESR1 expression extending to AP cells and crosstalk between growth factors and Estrogen Receptor signaling being evident in these AP cells. In general, cell subtype-specific gene expression did not uniformly correlate with cell-specific chromatin accessibility, suggesting that transcriptional regulation independent of chromatin accessibility governs cell type-specific gene expression in the breast.
“…Epithelial cell types were annotated using CD49f/EpCAM markers as done previously into mature luminal (ML), luminal progenitors (LP) and basal cells 11 . These cell clusters have been described with various names in the literature 7,8,12 . In a recent breast cell annotation event organized by Chan-Zuckerberg Initiative that included several research groups involved in developing single cell atlas of the breast, the following terminologies were suggested: luminal hormone sensing (LHS), luminal adaptive secretory precursor cells (LASP) and basal-myoepithelial (BM) cells for mature luminal, luminal progenitor, and basal cells, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…Murrow et al characterized premenopausal breast tissue at the single cell level to determine coordinated transcriptional programs that alter in response to changing hormonal levels 9 . Two other single cell studies using reduction mammoplasty samples identified three major epithelial cell types in the breast 10,12 . However, there remains a lack of information in differences in cell state based on genetic ancestry and relationship between cell state as defined by transcriptome and chromatin accessibility status.…”
Single nuclei analysis is allowing robust classification of cell types in an organ that helps to establish relationships between cell-type specific gene expression and chromatin accessibility status of gene regulatory regions. Using breast tissues of 92 healthy donors of various genetic ancestry, we have developed a comprehensive chromatin accessibility and gene expression atlas of human breast tissues. Integrated analysis revealed 10 distinct cell types in the healthy breast, which included three major epithelial cell subtypes (luminal hormone sensing, luminal adaptive secretory precursor, and basal-myoepithelial cells), two endothelial subtypes, two adipocyte subtypes, fibroblasts, T-cells, and macrophages. By integrating gene expression signatures derived from epithelial cell subtypes with spatial transcriptomics, we identify specific gene expression differences between lobular and ductal epithelial cells and age-associated changes in epithelial cell gene expression patterns and signaling networks. Among various cell types, luminal adaptive secretory cells and fibroblasts showed genetic ancestry dependent variability. A subpopulation of luminal adaptive secretory cells with alveolar progenitor (AP) cell state were enriched in Indigenous American (IA) ancestry and fibroblast populations were distinct in African ancestry. ESR1 expression pattern was distinctly different in cells from IA compared to the rest, with a high level of ESR1 expression extending to AP cells and crosstalk between growth factors and Estrogen Receptor signaling being evident in these AP cells. In general, cell subtype-specific gene expression did not uniformly correlate with cell-specific chromatin accessibility, suggesting that transcriptional regulation independent of chromatin accessibility governs cell type-specific gene expression in the breast.
“…2A). This held true on datasets from diverse organ systems and origins: Human Lung Cell Atlas (2.3 million cells [18]), the 1 million cell survey of embryonic development from Cao et al [19], the Human Breast Cell Atlas (800,000 cells [20]), and the DCM/ACM Heart Cell Atlas (881,000 cells [21]).…”
During development and differentiation, transcriptional regulation in the cell often occurs at the level of gene programs (i.e., sets of co-varying genes), rather than isolated genes. It is therefore crucial to identify differential program expression over time, or across case-vs-control samples. However, this has remained difficult: gene programs are inferred by analyzing gene coexpression, and mathematical operations on the latter are nontrivial. Gene coexpression is quantified as a symmetric positive-definite matrix, on which even basic quantities such as arithmetic differences are neither mathematically sound nor biologically interpretable. Here we exploit the structure of the Riemannian manifold of gene coexpression matrices to propose a novel abstraction of gene coexpression that is mathematically well-founded while being computationally tractable and statistically rigorous. Importantly, it also captures biological similarity better than standard coexpression. This conceptual advance enables us to introduce Sceodesic, an algorithm that invokes the log-Euclidean metric from differential geometry to quantify coexpression patterns specific to each cell state, and organizes them into a study-wide panel of interpretable gene programs. Applied to nine single-cell RNA-seq datasets, Sceodesic outperforms existing methods in early detection of cell fate commitment by leveraging differential expression of gene programs, and is also effective in discovering disease-linked programs in multi-sample studies. By respecting the manifold of gene coexpression matrices, Sceodesic resolves a longstanding challenge in relating biological variability to statistical analyses of single-cell RNA-seq data and enables the discovery of gene programs driving differentiation and disease.Software availabilityhttps://singhlab.net/Sceodesic
“…The breast biology field has invested greatly in dissecting human breast heterogeneity with over 1 million single cells across 200 human breast tissues profiled by scRNAseq to date 2,4,7,8,32 .…”
It has been nearly 3 decades since the discovery of theBRCA1/2genes and their link to breast cancer risk, with prophylactic mastectomy remaining the primary management option for these high-risk mutation carriers. The current paucity of interception strategies is due to undefined, targetable cancer precursor populations in the high-risk breast. Despite known cellular alterations in theBRCA1breast, epithelial populations at the root of unwarranted cell state transitions remain unresolved. Here, we identify a root progenitor population that is dysregulated inBRCA1carriers stemming from the metabolic role of BRCA1. This fatty-acid binding protein 7 (FABP7) expressing luminal progenitor population is spatially confined to the mammary ducts, has enhanced clonogenic capacity, and is the predicted origin of mixed basal-luminal differentiation in theBRCA1but notBRCA2breast. We show global H3K27 acetylation is reduced within ductal FABP7 cells inBRCA1carriersin situ, linking to a non-canonical metabolic role of BRCA1 in regulating acetyl-CoA pools andde novofatty acid synthesis. We demonstrate FABP7 progenitor capacity is preferentially ablated inBRCA1carriers through inhibition of fatty acid metabolism using an FDA-approved fatty acid synthase (FASN) inhibitor. This study lays the foundation for metabolic control of breast progenitor dynamics to mitigate breast cancer risk in theBRCA1breast.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.